UNSPSC 51162509: Carbetapentane/guaifenesin

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE302. This VA Drug Class (RE302) classifies this compound as belonging to the group NON-OPIOID-CONTAINING ANTITUSSIVES/EXPECTORANTS.

UNSPSC 51162509 Carbetapentane/guaifenesin is a Commodity code that in practice encompasses a far broader range of pharmaceutical products than its nominal scope suggests — state and local governments are buying generic multi-source pharmaceuticals, over-the-counter products, naloxone, and related medical supplies through this and related codes. Recent solicitations show county health departments and state cooperative purchasing alliances procuring finished pharmaceutical products in bulk for distribution to public health facilities, emergency response programs, and community health initiatives. Issuing bodies include county procurement offices (Seminole County, Florida) and state-level cooperative purchasing vehicles (Minnesota Multistate Cooperative Purchasing Alliance, administered by the Minnesota Department of Administration). The work typically requires vendors to supply products through authorized wholesaler networks, maintain current Good Manufacturing Practices and Drug Supply Chain Security Act compliance, hold specific insurance thresholds, and meet detailed product specification and delivery requirements on fixed or competitive pricing schedules.

Geographic activity centers on Minnesota and Florida based on recent postings. The Minnesota Multistate Cooperative Purchasing Alliance RFP (S1070000015802), posted January 20, 2026 with a March 26, 2026 response date, establishes multi-award contracts for generic pharmaceuticals and OTC products across participating state and local government facilities in Minnesota and Oregon, requiring vendors to supply through three authorized wholesalers and demonstrate EDI capability and pricing flexibility. Seminole County, Florida's IFB 60459723LAS, posted June 30, 2026 with a July 26, 2026 response date, sought 1,900 units of naloxone and 800 safe drug deactivation systems annually for quarterly delivery to the county's community health building. Both solicitations require comprehensive insurance coverage, E-Verify or equivalent employment verification, and compliance with federal environmental and manufacturing standards when federal funding applies.